You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 11, 2024

CLINICAL TRIALS PROFILE FOR ELAGOLIX SODIUM

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Elagolix Sodium

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00797225 ↗	Efficacy and Safety Study of Elagolix Versus Placebo or Leuprorelin Acetate in Endometriosis	Completed	AbbVie	Phase 2	2008-11-26	This study is designed to evaluate the safety and beneficial effects of elagolix (NBI-56418) compared to placebo and leuprorelin (an approved endometriosis therapy) over a three month period followed by an additional three months of treatment on elagolix.
NCT00797225 ↗	Efficacy and Safety Study of Elagolix Versus Placebo or Leuprorelin Acetate in Endometriosis	Completed	AbbVie (prior sponsor, Abbott)	Phase 2	2008-11-26	This study is designed to evaluate the safety and beneficial effects of elagolix (NBI-56418) compared to placebo and leuprorelin (an approved endometriosis therapy) over a three month period followed by an additional three months of treatment on elagolix.
NCT01931670 ↗	A Global Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain	Completed	AbbVie	Phase 3	2013-09-09	A randomized study evaluating the safety and efficacy of elagolix in the management of moderate to severe endometriosis-associated pain in adult premenopausal female subjects.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for Elagolix Sodium

Condition Name

Chart
Table

Condition Name for Elagolix Sodium
Intervention	Trials
Uterine Fibroids	5
Heavy Menstrual Bleeding	4
Endometriosis	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for Elagolix Sodium
Intervention	Trials
Menorrhagia	5
Leiomyoma	5
Hemorrhage	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Elagolix Sodium

Trials by Country

Map
Table

Trials by Country for Elagolix Sodium
Location	Trials
United States	215
Canada	8
Puerto Rico	5
Hungary	2
Poland	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for Elagolix Sodium
Location	Trials
Louisiana	7
Illinois	7
Georgia	7
Florida	7
Washington	7
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Elagolix Sodium

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for Elagolix Sodium
Clinical Trial Phase	Trials
Phase 3	7
Phase 2	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for Elagolix Sodium
Clinical Trial Phase	Trials
Completed	6
Active, not recruiting	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Elagolix Sodium

Sponsor Name

Chart
Table

Sponsor Name for Elagolix Sodium
Sponsor	Trials
AbbVie	8
AbbVie (prior sponsor, Abbott)	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for Elagolix Sodium
Sponsor	Trials
Industry	9
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.